Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01235455

Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors — POR-BetaPlus  

Relapsing Remitting Multiple Sclerosis (RRMS) Clinical Trial

Official title:
Portuguese BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis (MS) After Conversion to Betaferon by Using Elements of the BetaPlus Program

Clinical Trial Summary

This is an observational survey to assess the factors that influence adherence to Betaferon therapy in multiple sclerosis patients using elements of the BetaPlus support program, including the nurse support and auto-injectors. The patients were evaluated under normal clinical practice and were asked to fill out the quality of life FAMS questionnaire, Coping processes (WCQ) and depression questionnaire CES-D.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

  • Multiple Sclerosis
  • Multiple Sclerosis, Chronic Progressive
  • Multiple Sclerosis, Relapsing-Remitting
  • Relapsing Remitting Multiple Sclerosis (RRMS)
  • Sclerosis
  • Secondary Progressive Multiple Sclerosis (SPMS)
Clinical Trial Details
NCT number NCT01235455
Study type Observational
Source Bayer
Contact
Status Completed
Phase N/A
Start date August 2007
Completion date May 2011
View Details
See also
  Status Clinical Trial Phase
Terminated NCT01499667 - Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Switching From Natalizumab to Fingolimod Phase 3
Completed NCT00787657 - Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment N/A
Completed NCT02035514 - Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis Phase 1/Phase 2
Completed NCT00428584 - RNF and Betaseron® Tolerability Study Phase 3
Completed NCT05242133 - Efficacy and Safety of Peginterferon Beta-1a (CinnaGen) in Participants With Relapsing Remitting Multiple Sclerosis Phase 3
Completed NCT01125475 - A Scandinavian Non-interventional Study of Adherence to RebiSmart Administered Rebif New Formulation (RNF) Treatment in Relapsing Remitting Multiple Sclerosis (RRMS) Subjects N/A
Completed NCT00871780 - A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Phase 4